Welcome to our dedicated page for Tabula Rasa HealthCare news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa HealthCare stock.
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) is a leading healthcare company that specializes in personalized, comprehensive care for value-based care organizations. The company offers innovative service models and cutting-edge healthcare technology solutions that improve patient outcomes and maximize provider efficiency. Headquartered in Moorestown, New Jersey, TRHC focuses on optimizing medication management and delivering precise, individualized care to at-risk populations.
TRHC's core services include comprehensive pharmacy services, personalized medication management, and a suite of clinical and business management tools. These tools help health plans and provider groups optimize utilization and improve patient health. The company's technology-enabled solutions are designed to reduce risk, enhance medication efficacy, and improve overall healthcare efficiencies.
In recent developments, TRHC has entered into a definitive agreement to be acquired by Nautic Partners for $10.50 per share in cash, valuing the company at approximately $570 million. This acquisition is set to combine TRHC with ExactCare Pharmacy, another portfolio company of Nautic, enhancing the reach and capabilities of both entities. The merger is expected to close in the fourth quarter of 2023, subject to customary closing conditions.
TRHC's recent financial performance has been strong, with significant organic growth in its core PACE (Program of All-Inclusive Care for the Elderly) market. The company has focused on developing and expanding partnerships with risk-bearing healthcare organizations, aiming to serve the most complex care needs. This strategic focus has led to impressive financial results and increased profitability.
For those interested in the latest updates, TRHC will hold a conference call and webcast to discuss its second quarter 2023 financial results on August 8, 2023. The company continuously updates its stakeholders through its Investor Relations section on its website, providing access to financial results, earnings calls, and other significant announcements.
Tabula Rasa HealthCare (TRHC) has announced a partnership with TrackMy Solutions to enhance its vaccine verification management service, TrackMy VeriVax. The service aims to help large employers and academic institutions efficiently manage COVID-19 vaccination status through HIPAA-compliant technology. Key features include independent vaccine verification, COVID vaccine administration, and screening processes. Both companies emphasize the importance of providing organizations with a secure solution that ensures employee safety and verification. TRHC continues to leverage its medication safety solutions to improve patient outcomes.
Tabula Rasa HealthCare (TRHC) has secured a three-year contract renewal with PACE of the Triad to provide CareKinesis medication risk mitigation and pharmacy services. This extension underscores TRHC's commitment to enhancing medication safety for over 200 individuals served by PACE in Greensboro, NC. Since their partnership began in 2017, TRHC has focused on polypharmacy and medication safety, utilizing proprietary technology to mitigate adverse drug events. The continued collaboration emphasizes the effectiveness of CareKinesis in improving pharmacy operations and patient outcomes.
Tabula Rasa HealthCare (NASDAQ:TRHC) will hold a conference call to discuss its third quarter 2021 operating results on November 5, 2021, at 8:30 a.m. EDT. Financial results for the quarter ending September 30, 2021 will be released post-market on November 4, 2021. The call will feature CEO Calvin H. Knowlton, Co-Founder Orsula V. Knowlton, and CFO Brian W. Adams. Interested parties can access the call via TRHC's Investor Relations website or by dialing in with provided numbers. An audio replay will be available for a week following the event.
Tabula Rasa HealthCare, Inc. (TRHC) announced a Letter of Intent with the Pharmaceutical Association of Israel to advance its MedWise Science technology. This partnership aims to enhance medication safety among pharmacists in Israel and the Palestinian Authority. MedWise tools will help identify patients at risk for adverse drug events, potentially reducing preventable hospital visits and improving health outcomes. The initiative aligns with TRHC's goal to combat medication overload and enhance patient care.
CareVention HealthCare, a division of Tabula Rasa HealthCare (TRHC), announced a partnership with the National Adult Day Services Association (NADSA) to enhance adult day services across the U.S. This strategic collaboration aims to support aging populations by promoting the importance of adult day services in long-term care. CareVention will exhibit at NADSA's upcoming National Conference, presenting insights on PACE (Programs of All-Inclusive Care for the Elderly), which currently serves 57,000 participants in 30 states. The partnership emphasizes education and advocacy in improving care services.
Tabula Rasa HealthCare (TRHC) has been accepted as an affiliate member of the World Pharmacy Council, reinforcing its dedication to community pharmacists. This affiliation will enhance TRHC's ability to support medication safety through its MedWise® technology, which helps pharmacists identify patients at risk for adverse drug events. The World Pharmacy Council aims to improve community pharmacy services globally, and TRHC's involvement enables it to contribute data and expertise to this mission.
Tabula Rasa HealthCare (TRHC) announced at the ASCP Annual Meeting that a demonstration confirmed its MedWise® clinical decision support tools can significantly reduce the risk of adverse drug events in long-term care. The company has formed a partnership with ASCP to supply MedWise to its 5,000 pharmacist members, enhancing medication safety in senior care. TRHC's technology integrates pharmacogenomics and other factors to assess multi-drug interactions, aiming to improve patient outcomes and lower healthcare costs.
Tabula Rasa HealthCare (TRHC) reported growth in its PACE (Program of All-Inclusive Care for the Elderly) segment during the 2nd and 3rd quarters of 2021. The company welcomed 11 new PACE organizations and renewed 8 contracts, averaging 3.5 years with no attrition. No regulatory issues hinder growth, and TRHC anticipates launching 8 additional PACE programs in Q4. Their technology addresses medication safety, aiming to reduce adverse drug events, and supports value-based care.
Tabula Rasa HealthCare (TRHC) announced a conference call on September 28, 2021, at 11:00 a.m. ET, to discuss its peer-reviewed article series in The American Journal of Managed Care. The series focuses on an Innovative Enhanced Medication Therapy Management Model that aims to improve medication safety and healthcare outcomes. The call will feature CEO Calvin H. Knowlton, Chief Sales Officer Kevin Boesen, and Chief Scientific Officer Jacques Turgeon. Participants can join via phone or online at TRHC's investor site, with replay options available until October 5, 2021.
FAQ
What is the market cap of Tabula Rasa HealthCare (TRHC)?
What does Tabula Rasa HealthCare, Inc. do?
Where is Tabula Rasa HealthCare headquartered?
What recent acquisition involves Tabula Rasa HealthCare?
What are the core services provided by TRHC?
How does TRHC improve patient care?
What is PACE and how is TRHC involved?
What were TRHC's recent financial results?
When is TRHC's next financial results call?
What is the significance of TRHC's merger with ExactCare Pharmacy?
How can investors stay updated on TRHC's latest news?
